id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-E-0079-0006,FDA,FDA-2009-E-0079,Determination of Regulatory Review Period for Purposes of Patent Extension: TOVIAZ,Notice,N-Notice,2010-04-06T04:00:00Z,2010,4,2010-04-06T04:00:00Z,2010-06-08T03:59:59Z,2010-04-06T16:09:56Z,2010-07679,0,0,0900006480ad0824
FDA-2009-E-0079-0005,FDA,FDA-2009-E-0079,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-24T04:00:00Z,2010,3,2010-03-24T04:00:00Z,,2013-08-11T03:07:34Z,,0,0,0900006480ac78db